PeptideDB
en
EnglishEspañolDeutschPortuguês
PeptidesCategoriesCompareGuidesGlossary

Vesilute

Moderate research

ED Dipeptide | Bladder & Urinary Tract Bioregulator

OtherLongevity

Vesilute is a Khavinson bioregulator dipeptide consisting of glutamic acid and aspartic acid (ED), developed at the St. Petersburg Institute of Bioregulation and Gerontology.

Molecular & research data

Sequence
Glu-Asp (ED)
Molecular weight
262 Da
Half-life
Not established
Routes (research)
Injectable, Oral
Storage
Lyophilized powder: room temperature or 2-8°C; Reconstituted: 2-8°C refrigerated, use within 4 weeks

Overview

Vesilute is a Khavinson bioregulator dipeptide consisting of glutamic acid and aspartic acid (ED), developed at the St. Petersburg Institute of Bioregulation and Gerontology. It is specifically designed to support bladder and urinary tract function, with research indicating potential benefits for prostate health in men. Vesilute may help regulate smooth muscle function, enhance tissue blood flow, and support cellular regeneration in urogenital tissues. It is distinct from Vesugen (KED tripeptide), which targets vascular endothelium.

Mechanism of action

Vesilute acts on the smooth muscle cells and vascular endothelium of the urogenital system. It is proposed to: (1) regulate smooth muscle contraction and relaxation in the bladder wall, (2) enhance microcirculation and blood flow in pelvic tissues including prostate, (3) support cellular regeneration and tissue repair in the urinary tract, (4) reduce hyperemia and inflammation-related dysfunction, and (5) modulate gene expression related to urogenital tissue homeostasis through bioregulation pathways characteristic of Khavinson peptides.

Key research findings

  • Supports bladder and urinary tract function
  • May improve prostate health in men
  • Regulates smooth muscle function
  • Enhances pelvic tissue blood flow
  • Supports cellular regeneration
  • Part of comprehensive Khavinson bioregulator protocols
  • Well-tolerated in research
  • Oral bioavailability as small dipeptide

Research applications

Urinary Tract Health

  • Bladder Function Support — Research explores relief of symptoms associated with bladder dysfunction through smooth muscle regulation.
  • Urinary Tract Health — May support overall urinary tract function and tissue health.
  • Pelvic Floor Support — Potential benefits for pelvic tissue health and function.

Prostate Health (Men)

  • Prostate Support — Research indicates potential to enhance blood flow and reduce dysfunction in prostate tissue.
  • BPH Symptoms — May help alleviate symptoms associated with benign prostatic hyperplasia.

Anti-Aging Protocol

  • Urogenital Aging — Part of comprehensive bioregulator protocols addressing age-related urogenital changes.
  • Tissue Regeneration — Supports cellular regeneration in urinary and reproductive tissues.

Vesilute FAQ

Does Vesilute specifically help with prostate health or only bladder function?+

Vesilute targets both bladder smooth muscle function and prostate health through enhanced blood flow and tissue regeneration. Research indicates potential for relieving BPH (benign prostatic hyperplasia) symptoms, though clinical evidence is limited. The dipeptide's small size allows penetration into prostatic tissue for direct cellular effects.

How is Vesilute different from Prostamax or other prostate-targeting peptides?+

Vesilute (ED dipeptide) is a specific Khavinson bioregulator focusing on bladder and smooth muscle regulation, while Prostamax targets prostate tissue directly. They're complementary - Vesilute works on urinary tract function; Prostamax on prostate inflammation. Combining them may provide comprehensive urogenital support.

Can Vesilute improve urinary symptoms in women?+

While Vesilute is studied primarily in men for prostate support, its bladder smooth muscle regulatory and microcirculation enhancement effects could theoretically benefit women with bladder dysfunction or urinary symptoms. Gender-specific research is limited, but the mechanism suggests potential for both sexes.

How long does Vesilute take to improve urinary flow or BPH symptoms?+

Khavinson bioregulators typically require cycling (10-20 days on, then break) with improvements developing over 2-4 weeks during the first cycle. Maximum benefits emerge after multiple cycles (2-3 per year). Effects persist between cycles due to epigenetic changes, but bioregulator action is gradual compared to pharmaceutical diuretics.

References

  1. [1]Khavinson Bioregulator Peptides: Organ-Specific EffectsSt. Petersburg Institute of Bioregulation and Gerontology
  2. [2]Short Peptides and Urogenital FunctionRussian Medical Research
  3. [3]Bioregulators in Anti-Aging MedicineAdvances in Gerontology

Related peptides

Prostamax

Moderate research

KEDP Tetrapeptide | Prostate Bioregulator

Prostamax is a Khavinson bioregulator tetrapeptide (KEDP) with primary repair effects on prostate tissue. Developed by Professor Vladimir Khavinson at the St.

Sexual Health

Vesugen

Moderate research

KED | Vascular Bioregulator Peptide

Vesugen is a Khavinson bioregulator tripeptide developed at Russia's St. Petersburg Institute of Bioregulation and Gerontology.

LongevityRecovery & Healing

Epitalon

Preclinical

Tetrapeptide studied for telomere & pineal effects

Epitalon is a synthetic tetrapeptide derived from the pineal peptide epithalamin, studied primarily in Russian research for proposed effects on telomerase activity, circadian regulation, and ageing.

Longevity

Thymalin

Well studied

Thymic Peptide Bioregulator | Immune Modulator

Thymalin is a natural peptide bioregulator derived from calf thymus gland, developed in the Soviet Union in the 1970s.

ImmuneLongevity

Last reviewed: 2026-06-26. Information is provided for research and educational reference only — see our disclaimer.